[ELOS] Syneron Medical Ltd.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.8 Change: -0.05 (-0.56%)
Ext. hours: Change: 0 (0%)

chart ELOS

Refresh chart

Strongest Trends Summary For ELOS

ELOS is in the long-term down -76% below S&P in 20 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Syneron Medical Ltd., together with its subsidiaries, engages in the research, manufacture, development, marketing, and sale of aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. Its products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin?s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and topical skin brightening products. It also develops, manufactures, and markets non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle ar

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA17.46% ROE28.71% ROI
Current Ratio3.18 Quick Ratio3.04 Long Term Debt/Equity Debt Ratio0.48
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-3 M Cash From Investing Activities1.73 M Cash From Operating Activities-5.65 M Gross Profit32.69 M
Net Profit-1.47 M Operating Profit-1.35 M Total Assets293.3 M Total Current Assets188.66 M
Total Current Liabilities60.81 M Total Debt Total Liabilities69.36 M Total Revenue63.4 M
Technical Data
High 52 week11.2 Low 52 week6.35 Last close11 Last change0%
RSI58.06 Average true range0.84 Beta0.74 Volume30.57 K
Simple moving average 20 days0.35% Simple moving average 50 days0.71% Simple moving average 200 days14.83%
Performance Data
Performance Week0.46% Performance Month0.46% Performance Quart-0.9% Performance Half27.91%
Performance Year55.59% Performance Year-to-date30.95% Volatility daily0.25% Volatility weekly0.56%
Volatility monthly1.15% Volatility yearly3.97% Relative Volume144.62% Average Volume529.01 K
New High New Low

News

2017-07-17 07:30:00 | Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company

2017-07-10 14:23:52 | ETFs with exposure to Syneron Medical Ltd. : July 10, 2017

2017-07-07 09:38:28 | Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : July 7, 2017

2017-06-22 15:25:07 | Waiting For Bigger Bids?

2017-06-21 08:45:40 | Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : June 21, 2017

2017-06-19 15:16:01 | ETFs with exposure to Syneron Medical Ltd. : June 19, 2017

2017-06-16 12:04:38 | Syneron Medical Ltd. :ELOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017

2017-06-15 09:22:00 | Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax Partners

2017-06-15 08:15:00 | Featured Company News - Zimmer Biomet's China Manufacturing Unit Gets US FDA Nod After Addressing Violations Indicated in Warning Letter

2017-05-29 08:20:39 | Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : May 29, 2017

2017-05-18 14:13:54 | Syneron Medical Ltd. – Value Analysis NASDAQ:ELOS : May 18, 2017

2017-05-17 17:11:05 | Syneron Medical reports 1Q loss

2017-05-17 17:00:00 | Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million

2017-05-17 08:16:40 | Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : May 17, 2017

2017-05-10 06:00:00 | Syneron Candela Announces End of Go-Shop Period

2017-04-03 08:35:00 | Syneron Medical Ltd. stock rises after nearly $400 mln acquisition of outstanding shares

2017-04-03 07:44:52 | Apax to buy Israeli aesthetic device firm Syneron for $397 million

2017-04-03 07:37:31 | Apax to buy Israeli aesthetic device firm Syneron for $397 million

2017-04-03 07:34:55 | Apax to buy Israeli aesthetic device firm Syneron for $397 mln

2017-04-03 07:00:00 | Syneron Candela Announces Agreement to be Acquired by Funds advised by Apax Partners for $11.00/share in Cash, Representing an Approximate Value of $397 Million

2017-03-29 13:04:05 | SYNERON MEDICAL LTD. Financials

2017-03-23 16:10:00 | Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website

2017-03-01 15:05:00 | Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology AAD Annual Meeting

2017-02-16 11:24:36 | Syneron Medical Ltd. :ELOS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 16, 2017

2017-02-16 08:40:00 | Syneron Medical Reports 4Q Loss of 3 Cents a Share

2017-02-15 14:21:47 | Edited Transcript of ELOS earnings conference call or presentation 15-Feb-17 1:30pm GMT

2017-02-15 07:24:26 | Syneron Medical reports 4Q loss

2017-02-15 07:07:02 | Q4 2016 Syneron Medical Ltd Earnings Release - Before Market Open

2017-02-15 07:02:00 | 7:02 am Syneron Medical beats by $0.05, beats on revs

2017-02-15 07:00:00 | Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million

2017-02-14 11:48:44 | Hologic to buy Cynosure to expand into medical aesthetics

2017-02-14 10:03:11 | Hologic buys Cynosure to expand into medical aesthetics

2017-02-13 09:00:00 | Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference

2017-02-13 04:00:44 | Apax Partners in talks to buy Israel's Syneron Medical -report

2017-02-07 09:00:00 | Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors

2017-01-31 16:05:00 | Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer

2017-01-30 09:00:00 | Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017

2017-01-25 13:14:31 | ETFs with exposure to Syneron Medical Ltd. : January 25, 2017

2016-12-09 13:21:28 | ETFs with exposure to Syneron Medical Ltd. : December 9, 2016

2016-12-09 11:14:04 | Top Ranked Momentum Stocks to Buy for December 9th

2016-12-09 05:26:46 | Hedge Funds Aren’t Crazy About Syneron Medical Ltd. ELOS Anymore

2016-12-08 05:55:10 | 5 Reasonable Breakout Stocks for Exceptional Returns

2016-11-28 12:06:37 | ETFs with exposure to Syneron Medical Ltd. : November 28, 2016

2016-11-23 10:14:09 | Syneron Medical Ltd. :ELOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016

2016-11-11 16:00:00 | Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum

2016-11-09 12:12:54 | Edited Transcript of ELOS earnings conference call or presentation 9-Nov-16 1:30pm GMT

2016-11-09 07:26:47 | Syneron Medical posts 3Q profit

2016-11-09 07:09:14 | Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million

2016-11-09 07:07:04 | Q3 2016 Syneron Medical Ltd Earnings Release - Before Market Open

2016-11-09 07:00:00 | Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million